Health Literacy in People With Chronic Obstructive Pulmonary Disease

December 13, 2021 updated by: Christine Råheim Borge, Lovisenberg Diakonale Hospital

Health Literacy. An Intervention on Organized Information and Health Care for People With Chronic Obstructive Pulmonary Disease (COPD)

Health literacy refers to personal and relational factors affecting a person's ability to acquire, understand and use information about health and health services. In a need assessment study it was found that, the health services need to focus on health literacy factors in the follow up of patients with chronic obstructive pulmonary disease (COPD).

Thus, this project evaluate the effect a of a health literacy partnership health promotion intervention (hospital, municipalities, university) after discharge from hospital with the use of motivational interviewing and tailored follow-ups on re-admission, health literacy, self-management quality of life and cost in people with COPD compared with usual care.

Study Overview

Study Type

Interventional

Enrollment (Actual)

130

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Oslo, Norway, 0440
        • Lovisenberg Diakonale Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Diagnosed with COPD,
  • Above 18 years,
  • Admitted to a medical department at the main intervention hospital, l
  • Live in the sites belonging to the intervention hospital.

Exclusion Criteria:

  • Not diagnosed with COPD,
  • Not above 18 years,
  • Not admitted to a medical department at the main intervention hospital, and
  • Not living in the sites belonging to the intervention hospital.
  • Cognitive failure
  • Patients that are investigated or treated for cancer

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Health literacy intervention group
Health literacy intervention group will receive self-management help using a motivating interviewing technique delivered by nurses trained on motivating interviewing technique and COPD.
In the health literacy intervention group all patients will receive self-management help using a motivating interviewing (MI) technique delivered by two MI and COPD trained nurses once a week for eight weeks after hospitalization. Subsequently, the contact between the patients and the nurses will be by follow up motivational telephone calls once a month or more if needed for four months (i.a a total of six months intervention period).
No Intervention: Usual care group
Usual care group will receive usual follow up

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of admissions
Time Frame: Eight weeks, six months and one year
Number of re-admissions
Eight weeks, six months and one year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of health literacy
Time Frame: Eight weeks, six months and one year
Questionnaire
Eight weeks, six months and one year
Change of disease specific quality of life
Time Frame: Eight weeks, six months and one year
Questionnaire
Eight weeks, six months and one year
Change of e-Health
Time Frame: Eight weeks, six months and one year
Questionnaire
Eight weeks, six months and one year
Change of physical function
Time Frame: Eight weeks, six months and one year
Questionnaire
Eight weeks, six months and one year
Change of self-management
Time Frame: Eight weeks, six months and one year
Questionnaire
Eight weeks, six months and one year
Change of psychological stress
Time Frame: Eight weeks, six months and one year
Questionnaire
Eight weeks, six months and one year
Change of self-efficacy
Time Frame: Eight weeks, six months and one year
Questionnaire
Eight weeks, six months and one year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Christine Borge, Phd, University of Oslo and Lovisenberg Diaconal Hospital
  • Study Chair: Astrid K. Wahl, Phd, University of Oslo

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2017

Primary Completion (Actual)

December 31, 2020

Study Completion (Actual)

December 31, 2020

Study Registration Dates

First Submitted

July 7, 2017

First Submitted That Met QC Criteria

July 12, 2017

First Posted (Actual)

July 13, 2017

Study Record Updates

Last Update Posted (Actual)

December 14, 2021

Last Update Submitted That Met QC Criteria

December 13, 2021

Last Verified

December 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Obstructive Pulmonary Disease

Clinical Trials on Health literacy intervention group

3
Subscribe